NEWS HIGHLIGHTS RELATED TO ALKERAN INJECTION
Media Articles Related to Alkeran Injection (Melphalan)
melphalan-oral, Alkeran
Source: MedicineNet Amyloidosis Specialty [2005.03.02]
Bortezomib (Velcade) in Combo Scores For Initial Myeloma Treatment
Source: MedPageToday.com - Latest medical news and health news plus CME for physicians and healthcare professionals [2008.08.27]
MMRC Partners With Celgene Corporation On Phase I/II Trial Of Pomalidomide In Relapsed And Refractory Multiple Myeloma Patients
Source: Blood / Hematology News From Medical News Today [2008.08.26]
Bristol-Myers Squibb And PDL BioPharma Enter Global Alliance To Develop Novel Treatment For Multiple Myeloma
Source: Blood / Hematology News From Medical News Today [2008.08.21]
The Multiple Myeloma Research Consortium Announces Initiation Of First Four-Drug Combination Study To Treat Newly Diagnosed Multiple Myeloma Patients
Source: Blood / Hematology News From Medical News Today [2008.08.18]
Published Studies Related to Alkeran Injection (Melphalan)
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized, controlled trial. [2008.05.27]
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. [2007.10.06]
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. [2007.09.13]
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7. [2007.01]
Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients. [2006.11]
Clinical Trials Related to Alkeran Injection (Melphalan)
Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma [Terminated]
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients [Completed]
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor [Active, not recruiting]
Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT) [Active, not recruiting]
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. [Active, not recruiting]
|
